[Lab] GGPeps survo — VendorInvestigate came back 97.9% against a claimed 97.0%
GGPeps survo — VendorInvestigate came back 97.9% against a claimed 97.0%, and before anyone asks: same batch throughout, single submission, no cherry-picking between services. 97.9% and 97.0% — those are the numbers, and they are the ones I am willing to defend. Bought small because the evidence base is early. That…
Has anyone posted an independent purity result for this compound?
Is that a weight number from a different programme?
Yes — nothing containing this is approved anywhere, which is the first fact and usually the last one mentioned.
Agreed that the endpoint definitions matter enormously and almost nobody reads them before quoting a response rate.
research material is not approved for human use, which is why the clinical record here is thin
Are you reading the publication or a summary?
dual GLP-1 and glucagon agonist, and the glucagon arm is the story
Which endpoint — histological response, fibrosis improvement, or fat fraction?
Which phase and which arm are you quoting?
Small fix — dual agonist, GLP-1 and glucagon. No GIP arm in this molecule.